New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...
Aclarion noted that the timing update does not currently change the overall expected duration of the CLARITY trial, which remains on track under the company's original timeline.
Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions, today announced that management will participate in ...
New criteria fully approved at nine of eleven active sites expected to significantly accelerate enrollment paceInitial ...
Taking opioids for years does not seem to reduce pain or improve functioning in people with chronic back pain, according to a ...
Kirti had been trying to ignore the pain in her shoulder and upper arm for weeks. What she couldn’t ignore was the ‘zinging’ ...
Press Trust of India on MSN
Targeting brain's 'self-network' could be better approach to managing chronic pain, study finds
New Delhi, Oct 6 (PTI) A study has found that targeting the brain's default mode network, which becomes active when one is thinking about themselves and their identity or reflecting on internal ...
Low back pain is the single leading cause of disability worldwide, according to the World Health Organization.
Low back pain is the single leading cause of disability worldwide, according to the World Health Organization. For people ...
Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company") a commercial-stage medical device company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results